The Block Firm secured two important wins in our case, Faulkner et al v. Acella Pharmaceuticals, on behalf of NP Thyroid patients. On Monday, July 10, the Court denied Acella’s attempts to limit the scope of the putative nationwide class in every respect and provided a firm roadmap for the upcoming class certification motion. Acella had asked the Court to strike Plaintiffs’ class definition and class allegation based on Plaintiffs seeking to represent a supposedly overbroad and “fail-safe” class. In a 24-page order, the Court rejected Acella’s arguments. As noted in this Law360 article, the Court went as far as to observe that certain parts of the defendants’ arguments were “a bit disingenuous,” clearing the way for class claims that potentially date back to 2010. Bloomberg also posted an article about this which you can read here . The next day, the Court rejected Acella’s attempts to hide damaging documents and ordered the company to produce information about its defective drugs. Our team at The Block Firm LLC looks forward to continuing to vigorously represent patients across the country who were injured by Acella’s fraudulent and unsafe conduct.
If you would like more information on The Block Firm’s case against Acella, please click here.
Let us help you
August 9, 2023
Appellate Win: Max Marks Secures Unanimous Opinion Upholding $700,000 Jury Verdict in Punitive Damages Case for Georgia Peach Farmer.
July 17, 2023
NP Thyroid Class Action Win: Court Denies Acella’s Motion to Strike
June 23, 2023
Hospital Privacy Violations – Is Your Medical Information Safe?
June 22, 2023
Appellate Win for Civil Rights Client
June 15, 2023
Civil Rights Win: The Block Firm Beats Summary Judgment in Every Respect on Behalf of their Clients, The Diaz Family
April 6, 2023
Workplace harassment and discrimination FAQ’s
March 27, 2023
Civil Rights Win: Andrea Block Secures Early Confidential Settlement Against School District in Case Involving Sexual Abuse of a Special Needs Student
March 14, 2023